Tokyo, Japan

Sho Funayama


 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Sho Funayama

Introduction

Sho Funayama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical materials and treatments, particularly focusing on eye diseases. With a total of 5 patents to his name, Funayama's work has garnered attention for its innovative approaches and practical applications.

Latest Patents

Among his latest patents, Funayama has developed a chondroitin sulfate derivative that features a cross-linked structure through a group in a polyvalent amine. This invention includes a composition containing the chondroitin sulfate derivative, which serves as a treatment agent for eye diseases. The agent and method he has provided demonstrate therapeutic effects on corneal epithelial disorders and dry eye conditions. Additionally, he has created a diamine crosslinking agent for acidic polysaccharides, which consists of a diamine compound with primary amino groups at both terminals. This invention also includes a medical material that incorporates the crosslinked product.

Career Highlights

Sho Funayama is currently associated with Seikagaku Corporation, where he continues to innovate and develop new medical solutions. His work has been instrumental in advancing treatments that address significant health issues, particularly in ophthalmology.

Collaborations

Funayama has collaborated with notable coworkers, including Risa Nodera and Takahiro Hatanaka. Their combined expertise has contributed to the successful development of innovative medical materials and treatments.

Conclusion

Sho Funayama's contributions to the field of medical inventions highlight his dedication to improving health outcomes through innovative solutions. His patents reflect a commitment to addressing complex medical challenges, particularly in the realm of eye care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…